Why is SHC down?
Down 10% on Nov 3, and still 7% under its Nov 2 close.
“Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results.”
Down 10% on Nov 3, and still 7% under its Nov 2 close.
“Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results.”
SHC's Quality Score fell 2 points on Tue, Nov 10, to 3. It closed away from its high of the day (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| The company | Profit up 213% to $173M |
| Latest filing | 8-K, Nov 3 |
Mon Nov 16: Jefferies 17th Annual London Global…Investor conference · date confirmed.
1 more date ahead: the conference, for Pro members.
After its last 4 reports it closed -2.3% on average, higher 1 of 4 times.
SHC is #5 of 5 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| 5 |
Expected to report Tue Feb 23, before the open (in 105 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $324.9M, 4% more than a year ago; a profit of $0.20 a share, from $0.17.
“The change in third-quarter net revenues and segment income for the quarter was driven by unfavorable volume and mix due to the expected timing of Co-60 harvest schedules and foreign exchange, partially offset by favorable pricing.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Service | $277M | $278M | $256M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 3)
| Measure | Figure |
|---|---|
| Foreign currency benefit to net revenues and adjusted EBITDA | 70 basis points |
Sales grew 7.3% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 3.8% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 3, 2026 | -3.4% | -9.6% | -7.3% |
| Aug 6, 2026 | +3.2% | +5.2% | +5.1% |
| May 5, 2026 | -4.3% | -0.4% | +0.3% |
Sales grew every year from 2019 to 2025, to $1.2B. It made a profit in four of the seven years.
RSI 35.9, MACD below signal, below both averages. Not scored.
2 insiders sold $24M across 3 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: SHC is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
SHC scores 3 today, which Breakaway calls Below Average. It is #5 of 5 in Services-Miscellaneous Health & Allied Services by Quality Score, with 0 of 14 chart checks firing. Down 10% on Nov 3, and still 7% under its Nov 2 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
SHC scores 3 today, which Breakaway calls Below Average (0 to 5). That is #5 of 5 in Services-Miscellaneous Health & Allied Services by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SHC's 3.
2 insiders sold $24M across 3 filings in the last 6 months. No open-market buys on record. The newest is Michael B. Petras Jr., Executive Chairman, who sold $15.7M on Aug 17. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.